{"id":"W4410512909","doi":"10.3899/jrheum.2025-0390.pv257","title":"DOES ADDING CONCOMITANT IMMUNOSUPPRESSIVE THERAPY TO BELIMUMAB PROVIDE ADDITIONAL BENEFITS IN SLE? ANALYSIS FROM BEL-SPAIN: THE SPANISH BELIMUMAB MULTICENTER REGISTRY","year":2025,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Belimumab; Medicine; Concomitant; Multicenter study; Internal medicine; Immunology; Antibody; Randomized controlled trial; B-cell activating factor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01106433,0.0004488743,0.001258362,0.001662663,0.0003200327,0.001435324,0.001077301,0.0006048953,0.00364482],"category_scores_gemma":[0.01774545,0.0004014466,0.002050187,0.002638143,0.0003193278,0.0007228749,0.001263824,0.0007874727,0.0007317428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009128181,"about_ca_system_score_gemma":0.001177449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01178791,"about_ca_topic_score_gemma":0.01139791,"domain_scores_codex":[0.9939033,0.003109356,0.0007951816,0.001083037,0.0005427596,0.0005663427],"domain_scores_gemma":[0.9779455,0.006202173,0.008976707,0.00337936,0.002663072,0.0008332596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002253402,0.00005546439,0.989709,0.0001385216,0.001047314,0.0001017674,0.00007786284,0.0002525734,0.00006714252,0.00009316661,0.001516339,0.00468752],"study_design_scores_gemma":[0.0004411682,0.0003251638,0.99086,0.0001836923,0.001489649,0.0003479962,0.0004390601,0.0008112209,0.00009646297,0.0001501736,0.00482854,0.00002689756],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9789426,0.005023907,0.001034215,0.0006366022,0.00007334373,0.00006274517,0.01178944,0.00003674214,0.002400341],"genre_scores_gemma":[0.9836923,0.001258695,0.000508451,0.0003564918,0.00009918849,0.0001165877,0.01335865,0.00005133846,0.0005583094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01178791,"threshold_uncertainty_score":0.05851442,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01094054230970685,"score_gpt":0.257218990216979,"score_spread":0.2462784479072722,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}